Published in Curr Med Chem Anticancer Agents on May 01, 2004
Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg (2011) 2.86
Quantitative and qualitative 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in skull base meningiomas. Neurosurg Focus (2011) 2.22
Review of Neurosurgical Fluorescence Imaging Methodologies. IEEE J Sel Top Quantum Electron (2010) 1.29
Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgery. J Biomed Opt (2011) 1.23
Trends in fluorescence image-guided surgery for gliomas. Neurosurgery (2014) 1.03
5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningioma: qualitative and quantitative measurements in vivo. Neurosurgery (2014) 1.01
Amplifying the red-emission of upconverting nanoparticles for biocompatible clinically used prodrug-induced photodynamic therapy. ACS Nano (2014) 0.99
Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic Acid and 5-aminolevulinic acid derivatives. Antimicrob Agents Chemother (2008) 0.95
Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model. Photochem Photobiol (2009) 0.91
Analytic expression of fluorescence ratio detection correlates with depth in multi-spectral sub-surface imaging. Phys Med Biol (2011) 0.87
Noninvasive measurement of aminolevulinic acid-induced protoporphyrin IX fluorescence allowing detection of murine glioma in vivo. J Biomed Opt (2009) 0.87
What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas? Neurosurgery (2015) 0.86
Early neoplastic and metastatic mammary tumours of transgenic mice detected by 5-aminolevulinic acid-stimulated protoporphyrin IX accumulation. Br J Cancer (2005) 0.84
Mechanism for enhanced 5-aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomas. Oncotarget (2015) 0.83
Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay. Free Radic Biol Med (2011) 0.81
Optical technologies for intraoperative neurosurgical guidance. Neurosurg Focus (2016) 0.81
Protoporphyrin IX fluorescence contrast in invasive glioblastomas is linearly correlated with Gd enhanced magnetic resonance image contrast but has higher diagnostic accuracy. J Biomed Opt (2011) 0.80
Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery. Mol Imaging Biol (2016) 0.79
Multi-function microsystem for cells migration analysis and evaluation of photodynamic therapy procedure in coculture. Biomicrofluidics (2012) 0.78
Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response. Isr J Chem (2012) 0.78
Interference with the Jaffé method for creatinine following 5-aminolevulinic acid administration. Photodiagnosis Photodyn Ther (2010) 0.77
Synergistic Cytotoxic Effect of Gold Nanoparticles and 5-Aminolevulinic Acid-Mediated Photodynamic Therapy against Skin Cancer Cells. Iran J Med Sci (2014) 0.76
δ-Aminolevulinic acid and its methyl ester induce the formation of Protoporphyrin IX in cultured sensory neurones. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.76
Empirical Modeling of Physiochemical Immune Response of Multilayer Zinc Oxide Nanomaterials under UV Exposure to Melanoma and Foreskin Fibroblasts. Sci Rep (2017) 0.75
Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas. Oncol Lett (2016) 0.75
Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10-dimethyl-1,2-benzanthracene-treated hamsters. Oncol Lett (2013) 0.75
Mathematical model to interpret localized reflectance spectra measured in the presence of a strong fluorescence marker. J Biomed Opt (2016) 0.75
Fluorescence Lifetime Spectroscopy and Imaging in Neurosurgery. IEEE J Sel Top Quantum Electron (2012) 0.75
Photodynamic effects of zinc oxide nanowires in skin cancer and fibroblast. Lasers Med Sci (2013) 0.75
Feasibility of photodynamic therapy for secondary hyperparathyroidism in chronic renal failure rats. Clin Exp Nephrol (2016) 0.75
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control (2004) 2.04
The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res (2009) 1.86
Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Control Release (2008) 1.65
Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol (2009) 1.62
The importance of the depth distribution of melanin in skin for DNA protection and other photobiological processes. J Photochem Photobiol B (2006) 1.61
[Rhythms, depressions and light]. Tidsskr Nor Laegeforen (2006) 1.40
Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study. J Urol (2003) 1.33
Bacteria capture iron from heme by keeping tetrapyrrol skeleton intact. Proc Natl Acad Sci U S A (2009) 1.27
Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol (2009) 1.26
Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer (2007) 1.21
The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv Drug Deliv Rev (2007) 1.20
The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D. Int J Infect Dis (2010) 1.13
Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol (2011) 1.11
Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat (2006) 1.08
5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives. Photochem Photobiol (2007) 1.07
Milestones in the development of photodynamic therapy and fluorescence diagnosis. Photochem Photobiol Sci (2007) 1.05
Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B (2005) 1.04
Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer. Photochem Photobiol (2008) 1.03
Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol (2007) 1.03
Ultraviolet photodegradation of folic acid. J Photochem Photobiol B (2005) 1.03
Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv Drug Deliv Rev (2004) 1.02
Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv Exp Med Biol (2008) 1.02
Prostate cancer survival is dependent on season of diagnosis. Prostate (2007) 0.99
Seasonal variations of cancer incidence and prognosis. Dermatoendocrinol (2010) 0.98
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int J Pharm (2006) 0.96
Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic Acid and 5-aminolevulinic acid derivatives. Antimicrob Agents Chemother (2008) 0.95
Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries. Scand J Public Health (2010) 0.94
Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci (2004) 0.92
The effect of sub-lethal ALA-PDT on the cytoskeleton and adhesion of cultured human cancer cells. Biochim Biophys Acta (2004) 0.91
Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo. Photochem Photobiol Sci (2002) 0.91
Beneficial effects of UV radiation other than via vitamin D production. Dermatoendocrinol (2012) 0.91
Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J Control Release (2005) 0.90
Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization. Invest Ophthalmol Vis Sci (2008) 0.90
Vitamin D status in Norwegian children and adolescents with excess body weight. Pediatr Diabetes (2010) 0.89
Like a bolt from the blue: phthalocyanines in biomedical optics. Molecules (2011) 0.89
In vitro and in vivo photosensitization by protoporphyrins possessing different lipophilicities and vertical localization in the membrane. Photochem Photobiol (2007) 0.88
Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration. Invest Ophthalmol Vis Sci (2007) 0.88
Radiosensitization of tumours by porphyrins. Cancer Lett (2005) 0.88
Production of reactive oxygen species from photosensitizers activated with visible light sources available in dental offices. Photomed Laser Surg (2010) 0.87
Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol (2006) 0.86
Blue light-mediated inactivation of Enterococcus faecalis in vitro. Photodiagnosis Photodyn Ther (2012) 0.86
Biophysical aspects of photodynamic therapy. J Environ Pathol Toxicol Oncol (2006) 0.85
Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int J Cancer (2003) 0.85
Photodegradation of 5-methyltetrahydrofolate in the presence of Uroporphyrin. J Photochem Photobiol B (2008) 0.85
Polymeric photosensitizer prodrugs for photodynamic therapy. Photochem Photobiol (2007) 0.84
Novel patch-based systems for the localised delivery of ALA-esters. J Photochem Photobiol B (2010) 0.84
Choice of optimal wavelength for PDT: the significance of oxygen depletion. Photochem Photobiol (2005) 0.84
The relationship between UV exposure and incidence of skin cancer. Photodermatol Photoimmunol Photomed (2014) 0.84
The vitamin D status among Tibetans. Photochem Photobiol (2009) 0.84
Synergistic and tumour selective effects of chemotherapy and ultrasound treatment. Cancer Lett (2006) 0.83
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. Int J Pharm (2004) 0.83
Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy? Photochem Photobiol Sci (2008) 0.83
Serum 25-hydroxyvitamin D is a predictor of serum 1,25-dihydroxyvitamin D in overweight and obese patients. J Nutr (2010) 0.83
Reflectance spectra of pigmented and nonpigmented skin in the UV spectral region. Photochem Photobiol (2004) 0.83
Development of different human skin colors: a review highlighting photobiological and photobiophysical aspects. J Photochem Photobiol B (2009) 0.83
5-Methyltetrahydrofolate is photosensitive in the presence of riboflavin. Photochem Photobiol Sci (2008) 0.83
5-ALA derivative-mediated photoinactivation of Propionibacterium acnes. J Dermatol Sci (2009) 0.82
Photostability of commercial sunscreens upon sun exposure and irradiation by ultraviolet lamps. BMC Dermatol (2007) 0.82
Influence of narrowband UVB phototherapy on vitamin D and folate status. Exp Dermatol (2010) 0.82
Photodegradation of 5-methyltetrahydrofolate: biophysical aspects. Photochem Photobiol (2007) 0.82
Sun and sun beds: inducers of vitamin D and skin cancer. Anticancer Res (2009) 0.82
pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer. Cancer Lett (2003) 0.82
5-Methyltetrahydrofolate can be photodegraded by endogenous photosensitizers. Free Radic Biol Med (2009) 0.82
Chlorin e6-based photosensitizers for photodynamic therapy and photodiagnosis. Photodiagnosis Photodyn Ther (2009) 0.82
Targeting GLP-1 receptors for repeated magnetic resonance imaging differentiates graded losses of pancreatic beta cells in mice. Diabetologia (2014) 0.82
Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes. Bioconjug Chem (2007) 0.82
Time trends and latitude dependence of uveal and cutaneous malignant melanoma induced by solar radiation. Dermatoendocrinol (2010) 0.82
The effect of skin permeation enhancers on the formation of porphyrins in mouse skin during topical application of the methyl ester of 5-aminolevulinic acid. J Photochem Photobiol B (2006) 0.82
UVA, UVB and incidence of cutaneous malignant melanoma in Norway and Sweden. Photochem Photobiol Sci (2011) 0.82
Vitamin D status in healthy Romanian caregivers and risk of respiratory infections. Public Health Nutr (2012) 0.81
Vitamin D, sun, sunbeds and health. Public Health Nutr (2011) 0.81
Influenza, solar radiation and vitamin D. Dermatoendocrinol (2009) 0.81
Sun beds and cod liver oil as vitamin D sources. J Photochem Photobiol B (2008) 0.81
Photodynamic inhibition of enzymatic detachment of human cancer cells from a substratum. Biochim Biophys Acta (2004) 0.81
Erythrocytes-the 'house elves' of photodynamic therapy. Photochem Photobiol Sci (2004) 0.80
Depth profile of protoporphyrin IX fluorescence in an amelanotic mouse melanoma model. Photochem Photobiol (2008) 0.80
Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007. J Photochem Photobiol B (2010) 0.80
A new method for photodynamic therapy of melanotic melanoma -- effects of depigmentation with violet light photodynamic therapy. J Environ Pathol Toxicol Oncol (2007) 0.80